C
Csaba P. Kovesdy
Researcher at University of Tennessee Health Science Center
Publications - 649
Citations - 41377
Csaba P. Kovesdy is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 92, co-authored 605 publications receiving 31462 citations. Previous affiliations of Csaba P. Kovesdy include University of California, Irvine & Semmelweis University.
Papers
More filters
Journal ArticleDOI
International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.
Yejin Mok,Shoshana H. Ballew,Lori D. Bash,Deepak L. Bhatt,William E. Boden,Marc P. Bonaca,Juan Jesus Carrero,Josef Coresh,Ralph B. D'Agostino,C Raina Elley,F. Gerry R. Fowkes,Sun Ha Jee,Csaba P. Kovesdy,Kenneth W. Mahaffey,Girish N. Nadkarni,Eric D. Peterson,Yingying Sang,Kunihiro Matsushita +17 more
TL;DR: TRS2°P, a simple scoring system with 9 routine clinical factors, was modestly predictive of secondary events when applied in patients with recent myocardial infarction from diverse clinical and geographic settings.
Journal ArticleDOI
Effect of Age on the Association of Vascular Access Type with Mortality in a Cohort of Incident End-Stage Renal Disease Patients.
Tarek Saleh,Keiichi Sumida,Miklos Z. Molnar,Miklos Z. Molnar,Praveen K. Potukuchi,Fridtjof Thomas,Jun Ling Lu,Geeta Gyamlani,Elani Streja,Kamyar Kalantar-Zadeh,Csaba P. Kovesdy,Csaba P. Kovesdy +11 more
TL;DR: Although most of the patients consisted of male veterans and the results may not be generalized to the general population, the use of TDCs is associated with poor outcomes even in the most elderly incident HD patients.
Journal ArticleDOI
Association of aspartate aminotransferase with mortality in hemodialysis patients
Vanessa A. Ravel,Elani Streja,Miklos Z. Molnar,Sepideh Rezakhani,Melissa Soohoo,Csaba P. Kovesdy,Csaba P. Kovesdy,Kamyar Kalantar-Zadeh,Hamid Moradi,Hamid Moradi +9 more
TL;DR: Higher AST level of >20 IU/L is incrementally associated with higher mortality in MHD patients whereas AST in the 15-20IU/L range is associated with the greatest survival.
Journal ArticleDOI
Pre-end-stage renal disease visit-to-visit systolic blood pressure variability and post-end-stage renal disease mortality in incident dialysis patients.
Keiichi Sumida,Miklos Z. Molnar,Miklos Z. Molnar,Praveen K. Potukuchi,Fridtjof Thomas,Jun Ling Lu,Kunihiro Yamagata,Kamyar Kalantar-Zadeh,Csaba P. Kovesdy,Csaba P. Kovesdy +9 more
TL;DR: High pre-ESRD SBPV is potentially modifiable and associated with higher all-cause and infection-related mortality following dialysis initiation, and further studies are needed to test whether modification of pre- ESRDSBPV can improve clinical outcomes in incident ESRD patients.
Journal ArticleDOI
Bicarbonate Therapy in End-Stage Renal Disease: Current Practice Trends and Implications.
TL;DR: This review will describe the pathophysiology and consequences of metabolic acidosis and its therapy in CKD and ESRD, and discuss current evidence supporting a more individualized approach for bicarbonate therapy in MHD.